,
your personalized virtual assistant to find clinical trials. Go head, 
David P Ryan, MD
Massachusetts General HospitalBoston, Massachusetts - 02114 |
- CLINICAL TRIALS 9
- CONDITIONS11
- INTERVENTIONS16
- SINCE2007
Perioperative Panitumumab and Epirubicin Oxaliplatin and Xeloda (EOX) in Patients With Gastroesophageal Adenocarcinoma
April 2008 - April 2011
Study of the Safety and Efficacy of TH-302 in Combination With Gemcitabine Compared With Gemcitabine Alone in Previously Untreated Patients With Pancreatic Adenocarcinoma
June 2010 - January 2012
Phase I/II Study of Panitumumab Capecitabine and Oxaliplatin w EBRT for Esophageal Cancer
December 2007 - October 2011
Enoxaparin Thromboprophylaxis in Cancer Patients With Elevated Tissue Factor Bearing Microparticles
May 2009 - April 2011
AMG 479 in Advanced Carcinoid and Pancreatic Neuroendocrine Tumors
March 2010 - November 2011
Cisplatin Irinotecan and Bevacizumab (PCA) Versus Docetaxel Cisplatin Irinotecan and Bevacizumab (TPCA) in Metastatic Esophageal and Gastric Cancer
July 2009 - July 2011
Cetuximab 5-FU and Radiation as Neoadjuvant Therapy for Patients With Locally Advanced Rectal Cancer
January 2008 - April 2011
RAD001 and Temozolomide in Patients With Advanced Pancreatic Neuroendocrine Tumors
May 2008 - December 2010
Pasireotide in Combination With RAD001 in Patients With Advanced Neuroendocrine Tumors
October 2008 - December 2010
Colonic Neoplasms
Lung Neoplasms
Adenocarcinoma
Pancreatic Neoplasms
Esophageal Diseases
Esophageal Neoplasms
Stomach Neoplasms
Rectal Neoplasms
Neuroendocrine Tumors
Carcinoid Tumor
Adenoma, Islet Cell
Bevacizumab
Cisplatin
Docetaxel
Gemzar (Gemcitabine)
Temozolomide
Rad001
Irinotecan
Enoxaparin
Cetuximab
5-Fluorouracil
Th-302
Panitumumab, Epirubicin, Oxaliplatin, Xeloda
Panitumumab, Oxaliplatin, Capecitabine And Ebrt
Amg 479
External Beam Pelvis Radiation Therapy
Som230
